Effects of Dexamethasone on Common Bile Duct Cannulation Time
Common Bile Duct Diseases, Common Bile Duct Calculi, Common Bile Duct Stricture
About this trial
This is an interventional treatment trial for Common Bile Duct Diseases focused on measuring ERCP, Steroids, Dexamethasone, CBD cannulation time
Eligibility Criteria
Inclusion Criteria: Age: 18 years or above Both genders, male and female patients Exclusion Criteria: Age younger than 18 years or below Pregnant females Pre existing stent in CBD or pancreatic duct Previous history of ERCP Patients with billroth II surgery Anatomical abnormalities Lack of competence in patients Roux en Y gastric bypass Patients with contra indications for steroids like DM
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Dexa Arm
NS Arm
Experimental arm patients will be receiving 2 ml (4mg) of dexamenthasone prior to undergoing ERCP.
Placebo arm patients will be receiving 2 ml of normal saline prior to undergoing ERCP.